Cosmetic cross-reference Noindex: medium evidence

Phosphorus

CAS 7723-14-0

Phosphorus (CAS 7723-14-0) is a pharmaceutical compound with 0 bioactivity targets and 1,922 adverse event associations.

SOURCE NLM DailyMed
Label records
1
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
1,922
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE NLM DailyMed 20346FBA692B

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Phosphorus
CAS Number
7723-14-0
UNII
27YLU75U4W
InChIKey
OAICVXFJPJFONN-UHFFFAOYSA-N
Source Match
DailyMed Label Data
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE NLM DailyMed 1 label row

Drug Label Active Ingredients

Active ingredient and active moiety rows from source drug product labels.

ProductIngredient Active MoietyEffective
Calm PHOSPHORUS
27YLU75U4W
PHOSPHORUS 20260505
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Phosphorus used for in pharmaceutical contexts?

Phosphorus (CAS 7723-14-0) appears in DailyMed active-ingredient label rows, including Calm.

What are the known adverse events for Phosphorus?

Phosphorus has 1,922 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Accidental overdose. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Phosphorus also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Phosphorus with EU status "prohibited".

What clinical phase is Phosphorus in?

No phase 1-4 clinical development badge is rendered for Phosphorus because the matched compound identifier rows do not contain a max-phase value.